CEBPA and acute myeloid leukemia: CEBPα gene mutations may not only abolish the proliferation suppressive function of the full-length p42 CEBPα, but also correlate with the expression of lymphoid markers in AML cases (Wouters et al, 2008), suggesting that myelo-lymphoid lineage ambiguity could be achieved in both lineages by converging routes.